The effect of mild and moderate renal impairment on the pharmacokinetics of pridopidine, a new drug for Huntington's disease.
about
Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine.Update and trends on pharmacokinetic studies in patients with impaired renal function: practical insight into application of the FDA and EMA guidelines.Metoprolol-pridopidine drug-drug interaction and food effect assessments of pridopidine, a new drug for treatment of Huntington's disease.
P2860
The effect of mild and moderate renal impairment on the pharmacokinetics of pridopidine, a new drug for Huntington's disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The effect of mild and moderat ...... drug for Huntington's disease.
@ast
The effect of mild and moderat ...... drug for Huntington's disease.
@en
type
label
The effect of mild and moderat ...... drug for Huntington's disease.
@ast
The effect of mild and moderat ...... drug for Huntington's disease.
@en
prefLabel
The effect of mild and moderat ...... drug for Huntington's disease.
@ast
The effect of mild and moderat ...... drug for Huntington's disease.
@en
P2093
P2860
P356
P1476
The effect of mild and moderat ...... drug for Huntington's disease.
@en
P2093
A Rembratt
K E Siegler
L Rabinovich-Guilatt
O Spiegelstein
P2860
P304
P356
10.1111/BCP.12792
P407
P577
2015-09-25T00:00:00Z